We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
ZeptoMetrix an Antylia scientific company

EKF Diagnostics

Manufactures analysers for the measurement of glucose, lactate, hemoglobin, hematocrit and HbA1c for GP surgeries, ph... read more Featured Products: More products

Download Mobile App




POCT Offers Cost-Effective Convenience and Improved HbA1c Analysis

By LabMedica International staff writers
Posted on 09 Jul 2013
A glycated hemoglobin (HbA1c) analyzer for near-patient monitoring of diabetes is cost-effective and easy-to-use.

Called the Quo-Test, the compact analyzer will be demonstrated by BHR at Heart UK’s annual conference in Bristol (UK), during July 2013.

A product of EKF Diagnostics (Cardiff, United Kingdom), Quo-Test provides rapid measurement of HbA1c at the point-of-care (POC). More...
The analyzer provides lab-accurate results in only four minutes from 4 μL of venous or finger prick blood. This enables clinicians to make immediate decisions for a patient’s diabetes management and should result in improved diabetic control, better patient outcomes and enhanced clinic efficiency, with fewer patient visits, and subsequent economic benefits.

CE marked, Quo-Test is fully automated with intuitive step-by-step onscreen instructions minimizing training time. The compact analyzer also ensures efficient data handling, with a barcode reader included and storage of up to 7,000 results, which can be downloaded to a laboratory information system (LIS) via its USB port. The results are unaffected by hemoglobin variants because Quo-Test uses the boronate affinity method, which is interference free.

Andrew Greaves, BHR Sales Director, commented, “Due to the evident link between diabetes and heart disease, EKF Diagnostics’ Quo-Test is an ideal analyzer to showcase at this event [Heart UK] since it delivers easy and reliable measurement of HbA1c used for the detection and management of diabetes at the point-of-care.”

Related Links:

BHR
EKF Diagnostics



Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Verification Panels for Assay Development & QC
Seroconversion Panels
Complement 3 (C3) Test
GPP-100 C3 Kit
Gold Member
DNA Extraction Kit
MagMAX DNA Multi-Sample Ultra 2.0 Kit
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.